Trials / Completed
CompletedNCT04288895
Open-label, Flexible-dose Study of Vortioxetine in Patients With Depression in India
Open-label, Flexible-dose Study of Vortioxetine in Patients With Major Depressive Disorder in India
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 400 (actual)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and tolerability of flexible doses of vortioxetine (5 - 20 mg/day) over a period of 12 weeks in patients with depression in India
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vortioxetine | 5 - 20 mg/day flexible-dose vortioxetine, tablets, orally |
Timeline
- Start date
- 2020-02-20
- Primary completion
- 2022-02-11
- Completion
- 2022-03-12
- First posted
- 2020-02-28
- Last updated
- 2022-03-18
Locations
24 sites across 1 country: India
Source: ClinicalTrials.gov record NCT04288895. Inclusion in this directory is not an endorsement.